JUBLPHARMA.NS Balance Sheet

Jubilant Pharmova Ltd.

Balance Sheet · 8 years on file (FY2017-18 to FY2025-26) · fetched 2026-08-23 23:33

Line item	FY2017-18	FY2019-20	FY2020-21 standalone basis	FY2021-22	FY2022-23	FY2023-24	FY2024-25	FY2025-26	Source (XBRL element)
Property, Plant and Equipment	N/A	N/A	N/A	N/A	₹22.98 Bn	₹21.58 Bn	₹21.32 Bn	₹35.10 Bn	PropertyPlantAndEquipment
Capital Work-in-Progress	N/A	N/A	N/A	N/A	₹7.73 Bn	₹12.52 Bn	₹27.15 Bn	₹29.61 Bn	CapitalWorkInProgress
Goodwill	N/A	N/A	N/A	N/A	₹24.29 Bn	₹24.64 Bn	₹25.41 Bn	₹28.26 Bn	Goodwill
Other Intangible Assets	N/A	N/A	N/A	N/A	₹4.57 Bn	₹1.93 Bn	₹1.81 Bn	₹1.98 Bn	OtherIntangibleAssets
Non-current Investments	N/A	N/A	N/A	N/A	₹0.33 Bn	₹0.34 Bn	₹0.36 Bn	₹0.61 Bn	NoncurrentInvestments
Other Non-current Assets	N/A	N/A	N/A	N/A	₹1.47 Bn	₹4.60 Bn	₹3.67 Bn	₹4.90 Bn	OtherNoncurrentAssets
Total Non-current Assets	N/A	N/A	N/A	N/A	₹73.94 Bn	₹76.72 Bn	₹91.79 Bn	₹114.13 Bn	NoncurrentAssets
Inventories	N/A	N/A	N/A	N/A	₹13.81 Bn	₹12.90 Bn	₹11.29 Bn	₹12.31 Bn	Inventories
Trade Receivables	N/A	N/A	N/A	N/A	₹9.61 Bn	₹9.16 Bn	₹8.91 Bn	₹10.70 Bn	TradeReceivablesCurrent
Cash and Cash Equivalents	N/A	N/A	N/A	N/A	₹10.14 Bn	₹9.56 Bn	₹10.88 Bn	₹12.67 Bn	CashAndCashEquivalents
Current Investments	N/A	N/A	N/A	N/A	₹0.00 Bn	₹0.00 Bn	₹0.00 Bn	₹0.00 Bn	CurrentInvestments
Other Current Assets	N/A	N/A	N/A	N/A	₹2.65 Bn	₹2.05 Bn	₹2.21 Bn	₹2.49 Bn	OtherCurrentAssets
Total Current Assets	N/A	N/A	N/A	N/A	₹37.62 Bn	₹36.32 Bn	₹35.10 Bn	₹41.09 Bn	CurrentAssets
Total Assets	N/A	N/A	N/A	N/A	₹111.57 Bn	₹115.48 Bn	₹127.56 Bn	₹155.23 Bn	Assets
Equity Share Capital	N/A	N/A	N/A	N/A	₹0.16 Bn	₹0.16 Bn	₹0.16 Bn	₹0.16 Bn	EquityShareCapital
Other Equity	N/A	N/A	N/A	N/A	₹53.83 Bn	₹54.18 Bn	₹62.39 Bn	₹70.77 Bn	OtherEquity
Equity Attributable to Owners	N/A	N/A	N/A	N/A	₹53.99 Bn	₹54.34 Bn	₹62.55 Bn	₹70.93 Bn	EquityAttributableToOwnersOfParent
Non-controlling Interests	N/A	N/A	N/A	N/A	₹-0.07 Bn	₹-0.13 Bn	₹-0.16 Bn	₹0.03 Bn	NonControllingInterest
Total Equity	N/A	N/A	N/A	N/A	₹53.92 Bn	₹54.21 Bn	₹62.39 Bn	₹70.96 Bn	Equity
Long-term Borrowings	N/A	N/A	N/A	N/A	₹31.10 Bn	₹31.67 Bn	₹21.50 Bn	₹29.72 Bn	BorrowingsNoncurrent
Total Non-current Liabilities	N/A	N/A	N/A	N/A	₹39.92 Bn	₹42.38 Bn	₹43.53 Bn	₹58.88 Bn	NoncurrentLiabilities
Short-term Borrowings	N/A	N/A	N/A	N/A	₹3.00 Bn	₹2.47 Bn	₹2.87 Bn	₹2.48 Bn	BorrowingsCurrent
Trade Payables	N/A	N/A	N/A	N/A	₹8.21 Bn	₹8.56 Bn	₹10.05 Bn	₹12.34 Bn	TradePayablesCurrent
Other Current Liabilities	N/A	N/A	N/A	N/A	₹1.22 Bn	₹1.63 Bn	₹2.02 Bn	₹3.40 Bn	OtherCurrentLiabilities
Total Current Liabilities	N/A	N/A	N/A	N/A	₹17.72 Bn	₹18.89 Bn	₹21.65 Bn	₹25.39 Bn	CurrentLiabilities
Total Equity and Liabilities	N/A	N/A	N/A	N/A	₹111.57 Bn	₹115.48 Bn	₹127.56 Bn	₹155.23 Bn	EquityAndLiabilities

Every figure above is the exact value of the named XBRL element from JUBLPHARMA.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).